Philips | PHIA - Cash And Equivalent


Philips reported EUR1.79B in Cash and Equivalent for its fiscal quarter ending in June of 2026.





Cash And Equivalent Change Date
ABB USD 3.81B 57M Sep/2026
Abbott USD 6.8B 1.72B Mar/2026
Aena EUR 1.39B 1.56B Jun/2026
Alcon AG USD 1.58B 80M Mar/2026
ASM International NV EUR 1.18B 198.5M Jun/2026
ASML Holding EUR 8.03B 1.36B Sep/2026
AstraZeneca USD 4.89B 2.67B Jun/2026
Bayer EUR 4.29B 1.44B Jun/2026
Boston Scientific USD 539M 914M Jun/2026
Demant DKK 1.33B 188M Dec/2025
EDAP TMS EUR 15.01M 14.82M Mar/2026
Edwards Lifesciences USD 2.9B 500M Jun/2026
Essilor EUR 1.93B 1.61B Jun/2026
Fresenius EUR 2.06B 752M Mar/2026
Fresenius Medical Care EUR 1.06B 177.89M Jun/2026
Geberit CHF 403.6M 4.1M Mar/2025
Getinge SEK 2.05B 909M Jun/2026
GN Store Nord DKK 865M 254M Mar/2026
GRIFOLS EUR 513M 189M Jun/2026
HeidelbergCement EUR 2.54B 1.21B Dec/2025
Intuitive Surgical USD 6.8B 1.83B Sep/2026
Koninklijke Philips EUR 2.59B 680M Mar/2026
Legrand EUR 1.96B 23.7M Jun/2026
Lonza CHF 719M 188M Dec/2025
Medtronic USD 1.69B 258M Jun/2026
Merck EUR 2.74B 415M Mar/2026
Philips EUR 1.79B 803M Jun/2026
Sanofi EUR 6.35B 806M Jun/2026
SAP EUR 9.36B 1.15B Sep/2026
Schneider Electric EUR 4.63B 621M Dec/2025
Trinity Biotech USD 5.14M 3.8M Dec/2025